Millie
your market intelligence analyst
Search Results
103 results
Your search is now limited to «Chemotherapy» expert search.
Your search is now limited to only one Source. To return to results from all sources click here.
ClinicalTrials.gov 10/17/2019 08:27
Condition : Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) Interventions : Drug: Ibrutinib; Drug: Lenalidomide; Drug: Methotrexate; Drug: Rituximab; Drug: Etoposide; Drug: PEGylated recombinant human granulocyte colony Sponsor : Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting.
ClinicalTrials.gov 10/10/2019 08:47
Condition : Testicular Neoplasms Intervention : Other: Review of Health Information Sponsors : Walter and Eliza Hall Institute of Medical Research; Royal Marsden NHS Foundation Trust; Melbourne Health Active, not recruiting.
ClinicalTrials.gov 10/02/2019 07:48
Conditions : Chemotherapy; Diffuse Large B-Cell Lymphoma (DLBCL), Nos; Elderly Interventions : Drug: Rituximab; Drug: Lenalidomide 20 MG; Other: Comprehensive Geriatric Assessment (CGA); Other: Activities of daily living (ADL) scale Sponsors : Centre Hospitalier Universitaire, Amiens; cimiez hospital Nice; Institut Bergonié; groupe hospitalier public sud de l'oise; Henri Mondor University Hospital; Centre Henri Becquerel; Hôpital Charles Foix; Saint-Louis Hospital, Paris, France Not yet recruiting.
ClinicalTrials.gov 10/02/2019 07:48
Conditions : Pancreatic Cancer; Exocrine Pancreatic Insufficiency; Metastatic Pancreatic Cancer; Chemotherapy; Malnutrition; Locally Advanced Malignant Neoplasm Intervention : Sponsors : Moscow Clinical Scientific Center; University of Santiago de Compostela; University Clinic Dr Dragisa Misovic-Dedinje; University of Belgrade; Hospital General Universitario de Alicante; Faculty of Medicine, Istanbul University; European Institute of Oncology; IRCCS San Raffaele; Bucharest Emergency Hospital Recruiting.
ClinicalTrials.gov 10/02/2019 07:48
Condition : Acute Myeloid Leukemia Interventions : Drug: Quizartinib; Drug: Fludarabine; Drug: Cytarabine; Drug: Idarubicin; Drug: glycosylated G-CSF Sponsors : PETHEMA Foundation; Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Syntax for Science, S.L Not yet recruiting.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications